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METALLOSIS: METAL ION RELEASE FROM METAL-ON-METAL JOINT 
SURFACE REPLACEMENT ≠ CURRENT CONCERNS AND FUTURE 
PROBLEMS 
Stephen R. Manning 
Medical Education Centre, Sandwell General Hospital, Lyndon, West Bromwich, UK
Since its innovation, joint replacement surgery has offered relief from the pain and functional limitation of destructive or degen-
erate joint disease. The search for the ideal material continues over 120 years later. Recently, using metal-on-metal bearings for 
younger patients has become the trend to avoid excess wear in high demand patients in the hope of reducing the need to revision 
surgery. Initial evidence suggested these prostheses offered a durable, functional safe joint that was less likely to be revised than the 
standard metal and polyethylene joint. A body of evidence is growing rapidly to suggest that metal-on-metal joints are associated 
with local tissue reactions – metallosis – cellular toxicity, increased serum metal ion concentrations, organ deposition of metal 
ions, higher rather than lower rates of revision surgery and no functional advantage over any other type of joint replacement. 
We will consider the reasons for metal ion release; the cellular, local tissue and systemic effects of metal ions and the patient risk 
and presentation. From the evidence reviewed, serious consideration should be given to the future use of metal-on-metal joint 
bearings and a suggested follow up plan for patients with such joints is identified and reproduced. Biomed Rev 2011; 22: 57-64.
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INTRODUCTION
Joint replacement surgery is commonly performed by ortho-
paedic surgeons for patients with painful, destructive joint 
disease limiting their function and quality of life. It is little 
appreciated that joint replacement surgery was first described 
some 120 years ago. The Romanian born German surgical 
pioneer, Thermistocles Gluck (1853-1942) antedated the 
famous 20th Century pioneers such as Harboush (1), Wiltse 
(2) and Charnley (3) by more than 50 years. He was ahead 
of Küntsher (4) by some 50 years with the concept of intra-
medullary fracture fixation. His interest in bone defects was 
encouraged by his work in the Balkans as a wartime surgeon 
between 1877 and 1885. In his 1891 Treatise, Gluck, describes 
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his observation of a rudimentary external fixator. This was 
made by a mechanic, and used on a femoral fracture, due to 
a gunshot in Bulgaria in 1885-1886 (5). Gluck sought to de-
termine suitable material to replace diseased joints with. He 
describes implants made of aluminium, wood, glass, celluloid 
and nickel plated steel as being cheap and allowing healing 
without reaction. However, his favourite material was ivory. 
He described his experiments with cement “in particular the 
almost instantaneously congealing stone filler” which can be 
used as a filler or to provide security to his ivory implants. 
Even in 1891, with his excitement of pioneering a surgical 
advance Gluck urged caution. He foretold that wear and tear 
on the artificial joint could not be anticipated and loss of joint 
movements and ivory strength could result (5).
Wear of prosthetic joints remains a problem today. As 
we have passed through the 20th and into the 21st Century, 
joint replacements have evolved and become more common. 
Younger patients who expect higher levels of function and, 
naturally, have long life expectancies are being considered for 
hip surgery. A good functional result has been achieved based 
on the innovations of Sir John Charnley using polyethylene 
lined cups and metal femoral heads. However, high demand 
produces high levels of wear on the polyethylene cup liners 
and the potential need for revision surgery.
To withstand wear and provide a durable functional pros-
thetic joint metal-on-metal joints have evolved and procedures 
such as hip resurfacing offer a durable, functional, pain free 
joint whilst avoiding total hip replacement in the younger 
patient. Alternatively, total hip arthroplasty using metal compo-
nents with a large femoral head to cup size ratio can be offered 
to the younger patient. Some studies show good functional 
results are achieved (6). Rates of wear with metal-on-metal 
prostheses have been shown to be 20-100 times lower than 
metal on polyethylene (7) and revision rates specifically due 
to loosening or femoral fracture are low over a 5 year period 
(2-3.6%) (8,9). These studies provide an argument in favour 
of the use of metal-on-metal bearings but evidence to the 
contrary may outweigh this.
The choice of metal implanted into the human body is 
governed by several factors. It must resist corrosion in the 
hostile environment of human tissue. It must be durable for 
its purpose. It must be inert or bio-compatible. It must be 
compatible with other components implanted with it. Metal 
alloys have been found to be most suitable. Stainless steel is 
the least corrosion resistant of the currently used metals and 
is used more for temporary purposes. Titanium and cobalt-
chromium alloys do not corrode in the body however metal 
ions can diffuse out of the metals and into the body (10). 
In this review we will consider the problem of metal ion 
release from implanted material; consider what, if any, risk it 
may pose for patients, and consider whether there is sufficient 
advantage of metal-on-metal bearings to justify any risks. 
WEAR OF PROSThETIC JOINTS
The articular surfaces of prosthetic joints are subjected to 
repetitive motion as part of their normal function. During 
their manufacture, joint surfaces are highly polished to ensure 
a smooth gliding surface. Any micro-imperfections may be 
eroded after implantation by localised friction, especially if 
the joint surfaces are not well lubricated by synovial fluid.
Correct placement of the joint components is vital, the 
geometry of the prosthetic joint place will influence its func-
tion and stability. It has been shown that a steeply inclined 
acetabular component or a small femoral head size can lead 
to an abnormal pattern of “edge loading.” Edge loading is as-
sociated with increased rates of localised wear and in the case 
of metal-on-metal joints, higher serum metal ion concentra-
tions (11-14). Small femoral head size is also associated with 
impingement of the femoral neck on the edge of the acetabular 
cup, resulting in restricted movement of the joint and, again, 
edge loading and excessive wear of the components (14). 
Titanium alloy (Ti-6Al-4V) has been found to be susceptible 
to abrasive wear and it has been seen that one year after im-
plantation the articular surfaces become covered in a “scratch 
and gouge” pattern. This is especially seen if any loosening 
of the components occurs, allowing loose acrylic debris from 
cement or wear debris from a polyethylene acetabulum liner 
to interpose between the articular surfaces. This pattern of 
damage is associated with localised release of metal (15,16). 
Coupling of the components used in joint replacement is 
usually relatively straight forward – manufacturers provide 
both components as part of a set and the components are 
compatible with each other. Should any mis-pairing result then 
the outcome depends upon the metals involved. A reported 
case exists of an incompatible paring of cobalt-chromium and 
stainless steel leading to severe wear, local metal deposition 
and serum metal ion concentrations increased by a factor of 
20 (17). Cases of excessive wear are in the minority, a 10 year 
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follow up study of 100 metal-on-metal hip arthoplasties has 
found survivorship rates for the femoral component of 98% 
and the acetabular component 96% at 10 years, that is not 
requiring revision surgery (18).
CELLULAR EFFECTS OF METALS
Chromium is a trace element, present in the human body. In its 
hexavelent form (Chromuim VI) it is readily absorbed by the 
lungs, skin and mucous membranes and is toxic. Cobalt is also 
a trace element and forms an integral part of vitamin B12. The 
effects of metal particles upon cell culture have been studied in 
vitro. Cell cultures have been exposed to cobalt and chromium 
separately and as an alloy. Particles have been generated to be 
representative of those seen with wear upon a prosthetic joint. 
It has been seen that nano-particles of cobalt-chrome alloy are 
more toxic to fibroblast culture that micron sized particles. 
Nano-particles were more readily absorbed into fibroblasts. 
They break down readily and form an electron dense cloud 
within the cell, inducing aneuploidy and cytotoxicity. The 
effects were greater than those seen with larger micron sized 
particles (19). Cytotoxic effects upon fibroblasts have also 
been seen to be greater with metals containing a high cobalt 
concentration (20) and fibroblast viability can be reduced by up 
to 95% with concentrations of clinically relevant sized particles 
of 50 micromoles per cell (21). Following exposure to cobalt, 
fibroblasts show morphological changes when examined under 
the microscope. Nucleoli become darker staining, cytoplasmic 
processes are withdrawn and chromatin condenses irrevers-
ibly (pyknosis). Within the cell culture, following exposure 
to cobalt a significant rise in lactate dehydrogenase is seen, 
suggestive of cellular injury (22).
When osteoblasts are exposed to cobalt or titanium particles, 
the secretion of interleukin 8 (IL-8/CXCL8) and monocyte 
chemotactic protein-1 [MCP-1/ chemokine (C-C motif) ligand 
2 (CCL2)] is induced rapidly due to up-regulation of the corre-
sponding chemokine genes. The effect of chemokine secretion 
is to induce macrophages and neutrophils to migrate to the 
area. Osteoblast synthetic function is reduced in the presence 
of cobalt ions, as seen by reduced alkaline phosphatise activ-
ity and calcium deposition. The production of type I collagen, 
the predominant form in bone, is inhibited and the production 
of osteocalcin, a unique and abundant calcium binding bone 
protein is inhibited by colbalt. Chromium also inhibits osteo-
blast alkaline phosphatase (23,24). Macrophages attracted to 
the area by the osteoblast secretions absorb metal particles and 
secrete IL-1β, IL-8 and tumor necrosis factor-alpha (TNF-α), in 
a particle dependant manner. These cytokines have been shown 
to have a bone resorbing effect (25). In particular, high levels 
of IL-1 producing cells have been found at the bone-implant 
interface during revision surgery for implant loosening. The 
role of TNF-α in bone resorption and implant loosening has 
lead to its consideration as a therapeutic target in those who 
present with aseptic implant loosening (26). Along with IL-
1β producing macrophages, CD4+ T cells, helper T cells, are 
seen to be present in similar number but in excess of CD8+ T 
cells (27). The effect of metal debris T cell viability and func-
tion show some variability in the literature. Unlike fibroblasts 
viability has not been seen to be affected by metal debris in 
some in vitro studies, but proliferation has been seen to be 
inhibited by cobalt chromium molybedenum alloys, an effect 
not seen with titanium alloys (28). An opposite conclusion 
was reached by Hallab et al (29) who found in vitro that both 
Co-Cr-Mo and Ti alloys incubated with serum solutions led to 
a lymphocyte proliferative response, greatest when the metals 
formed metal-protein complexes. To add to this controversy, 
Akbar Brewer and Grant (30) found that at “clinically relevant” 
concentrations Cr6+ ions significantly decreased cell viability, 
proliferation and activation while increasing apoptosis. Co2+ 
also resulted in a decrease proliferation and cytokine response 
but no apoptosis.
LOCAL EFFECT OF METALS
At the local tissue level the effects of failing metal-on-metal 
bearings are well described. A frequent finding is blackening 
or grey staining of the tissues adjacent to the implant. These 
findings are described around the hip (31,32) the knee (33-35), 
the shoulder (36) and the spine (37). 
Soft tissue masses in the vicinity of metal-on-metal bearings 
are not infrequently described. These masses histologically, 
have been found to consist of macrophages, metal particles, 
lymphocytes, fibrin and necrotic tissue (31,38). Microscopic 
examination of macrophages found in these pseudo-tumours 
has shown them to be laden with black metallic particles (39). 
Lymphocytes within pseudo-tumours and surrounding tissues 
may be found diffusely spread throughout or concentrated in 
the peri-vascular areas. It has been seen that with higher grades 
of diffuse inflammation around a failing metal-on-metal bear-
ing is associated with an increasing extent of metal particles 
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in the tissue (40). As with inflammation from other causes, 
metallosis can lead to involvement of regional lymph nodes. 
Chromium containing histiocytes have been demonstrated in 
the enlarged pelvic lymph nodes of a patient 8 years after hip 
arthroplasty (41). 
The size of pseudo-tumours is variable, in some the tumour 
mass itself is the reason for presentation (42) or in others the 
effect of the mass on nearby structures giving rise to symptoms 
may trigger presentation (43,44). 
 As we have already seen, the effect of metals upon mac-
rophages and lymphocytes includes the secretion of bone 
resorbing cytokines at the implant-bone interface. This can 
lead to loosening of the implant and loss of optimum implant 
position (45-48), erosion of both trabecular and cortical bone 
(38,47,49,50) and trabecular micro-fractures of varying ages 
(51). 
SySTEMIC EFFECTS OF METALS
Metals released into the local tissues are absorbed into the 
blood stream. These metal ions are measurable in the serum 
and it has been seen that patients with metal-on-metal joint 
replacements have raised levels of cobalt and chromium in the 
blood and the urine (52). Blood levels can be several times 
the normal level but well within the limits of levels identified 
as toxic in metal industry workers. Metal ions are removed 
by the kidney and eliminated from the body in the urine (53). 
Chromium III ions have been seen, in vitro when mixed with 
human serum, to complex with albumin, transferin and im-
munoglobulins. The complexes formed were then more readily 
absorbed by macrophages than uncomplexed metal ions (54). 
Titanium ions are released from implants slowly and de-
spite being associated with local tissue metallosis, systemic 
diffusion levels are low. In sheep, following spinal fixation, 
in has been seen that at 24 months post surgery little systemic 
diffusion has taken place, at 36 months, titanium ions were 
present in all tissues (55). Human post mortem studies also 
demonstrate widespread distribution of metal ions through-
out the tissues. Within lymph nodes evidence of fibrosis and 
necrosis associated with metal laden macrophages has been 
seen. The presence of metal containing macrophages within 
the liver and spleen has been shown and although the amounts 
of metal are higher than is seen in the lymph nodes, dilution 
in these larger organs makes the overall metal concentration 
less. Up to ten years after arthroplasty, no evidence of necrosis 
or fibrosis was seen in the liver or spleen (56). The alteration 
of T cell function and viability discussed previously when 
combined with lymph node fibrosis and necrosis could lead 
to local immune dysfunction. Small increases, compared to 
control subjects, have been seen in levels of metal ions found 
in the frontal cortex of patients with worn metal on metal 
prostheses (56). The effects of cobalt and chromium ions on 
nervous tissue described include 1 case of reversible poly-
neuropathy with histological evidence of axonopathy (57). 
Two cases of femoral nerve neuropathy due to a pseudo-tumour 
mass with histological evidence of complete nerve destruction 
are also reported (58). Consideration has been given to metal 
ions released following arthroplasty as potential carcinogens. 
In has been postulated that chronic stimulation and alteration 
of lymphocyte function could lead to an increased risk of 
lymphoma or leukaemia (56,59).
It has been seen that concentrations of metal ions is higher 
in patients whose prosthesis is worn or is loose. This leads 
to the question, could serum levels of metal ions be used to 
identify worn, failing or loose prostheses? It has been sug-
gested that measurement of serum metal ions can be a useful 
adjunct to assessing metal-on-metal joints and a study has 
shown a good correlation between high levels of serum metal 
and wear on the joint surfaces (60). This may prove to be a 
sensitive indicator of wear if regular measurements are taken. 
The Medicines and Healthcare Products Regulatory Agency 
(MHRA) have recommended that patients with serum cobalt 
or chromium ion concentrations greater than 7µg/L should be 
further investigated. It was seen that 7 µg/L concentration of 
either ion, had a 90% specificity but only a 50% sensitivity 
for hip prosthesis failure (61).
hOW COMMON ARE PROBLEMS DUE TO METALOSIS?
The true incidence of metallosis is unknown as early pathology 
can be asymptomatic, diagnosis may be difficult, and reporting 
inaccurate (62). In 2011, the National Joint Registry for Eng-
land and Wales reported that all cause revision rates at seven 
years for primary hip replacements regardless of implant type 
were 4.7% (of a total of 285,600 primary operations) however, 
metal-on-metal bearings had all causes revision rates of 11.8% 
for resurfacing and 13.6% for replacement joints (63). It can 
be seen therefore, that revision rates, within seven years of 
surgery, for metal-on-metal bearings are higher than revision 
rates in general, despite the previously quoted evidence of a 
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lower revision rate when looking specifically at revisions for 
loosening or fracture (8,9). The vast majority of joints have 
not needed revision during this time, but this is not to say that 
asymptomatic pathology has not developed.
hOW DO PATIENTS PRESENT?
Initial symptoms may be vague and patients may present with 
groin, buttock or lateral hip discomfort. They may present with 
the sensation of a lump around the hip which may or may not 
be visible. Sensations of “clicking,” “clunking,” instability 
or dislocation are less common and may follow a period of 
discomfort. The mean time of presentation has been seen to 
be 17 months post primary surgery in one study (64). Rarely, 
patients may present with serious local symptoms such as 
nerve compression or vessel damage (43,44,65). 
The natural course of metallosis appears to be progressive 
once symptoms are present and revision surgery for deteriorat-
ing symptoms becomes necessary (66).
CONCLUSIONS AND FUTURE CONSIDERATIONS
At present we do not know how many patients will go on 
to develop symptoms following their metal on metal joint 
replacements or resurfacings, we may find that after several 
more years patients who had been initially asymptomatic run 
into difficulties. Long term effects of cobalt or chromium de-
posits in the liver are not well known. Although at 10 years, 
no necrosis or fibrosis has been seen in livers containing 
macrophages laden with cobalt or chromium (56) it is not 
known if this will be the case at 20 or more years. It has been 
suggested that there may be a link between metal-on-metal 
bearings and leukaemias or lymphomas (56,59) however, no 
definitive evidence has, to date, been described.
Revision surgery performed for metallosis is more difficult 
due to local tissue destruction and is associated with worse 
outcomes and more complications than revision surgery for 
other reasons including peri-prosthetic fractures (65,66).
Do the benefits of metal on metal bearings justify the po-
tential complications and risks? Recent meta-analysis shows 
that functional outcomes following metal-on-metal joint 
replacements compared to metal on polyethylene or ceramic-
on-ceramic joints offer no advantage but potentially metal-on-
metal bearings have a higher revision rate (67).
What about those patients who, with the best intentions, 
have been given a metal-on-metal bearing? What should be 
done for them? The MHRA (68) and British Orthopaedic As-
sociation have issued guidance summarised by Fary et al (66) 
and shown in box 1.
When looking at general revision rates for metal-on-metal 
bearings rather than rates specifically for loosening or fractures 
we see that revision rates are higher than for traditional metal 
on polyethylene joints and, as discussed the surgery is more 
difficult with a higher incidence of complications and poorer 
functional results. Potential disadvantages are described at the 
cellular, tissue and systemic level. Taken with the unanswered 
questions on long term metal toxicity for a joint which is of-
fering no functional advantage over any other currently used 
prosthesis we must seriously ask ourselves: should we be con-
tinuing to use metal on metal joint prostheses in our patients? 
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